Key Takeaways
- Stryker reported third quarter 2026 sales of US$6.52b and net income of US$753m, but also booked a US$293m goodwill impairment and cut its full year guidance.
- A goodwill impairment is a non-cash charge that tells investors management now believes an acquired business is worth less than the amount carried on the balance sheet.
- For CFA candidates, the skill is reading the charge as a signal: it hits reported earnings and equity, but not cash, and it often points to weaker future cash flows.
The Stryker quarter: a profit, a write-down and a guidance cut
Stryker, the medical technology group, reported third quarter 2026 results with sales of US$6.52b and net income of US$753m. Those are healthy numbers for a single quarter. Yet the same release included a US$293m goodwill impairment and a reduction to the company's full year guidance.
It is easy to read the headline profit and move on. A more careful reader asks two questions. Why did management decide the carrying amount of goodwill could not be defended? And does the guidance cut say something about the same underlying business trouble? This is goodwill impairment explained through a live example: the accounting entry and the business reality sit side by side.
What goodwill is, and why it can be wrong
Goodwill arises when one company buys another and pays more than the fair value of the target's identifiable net assets. The excess is recorded as an asset. It captures things such as expected synergies, workforce, customer relationships that are not separately recognised, and simply the buyer's optimism about the deal.
That last element is the problem. Goodwill is not amortised under US GAAP for public companies, and under IFRS it is also not amortised. It sits on the balance sheet at cost until something tells management it has lost value. Then it must be written down. In plain terms, an impairment is the acquirer admitting, in accounting language, that it overpaid or that the acquired business has since disappointed.
Stryker is a US company, so it reports under US GAAP. The broad logic is the same across frameworks, though the mechanics differ. Both require goodwill to be tested at least once a year, and sooner if there are warning signs. The frameworks differ in how they define the unit being tested and how they measure the shortfall. One difference candidates should remember: once goodwill is written down, it cannot be reversed later, even if the business recovers. The course covers the detailed comparison.
Reading the charge: what it does and does not change
The first point is that an impairment is non-cash. Stryker did not pay out US$293m this quarter because of the charge. The cash left the company when the original acquisitions were made. The write-down simply recognises that the earlier spending is now expected to earn less than hoped.
The second point is that it still matters. The charge reduces reported earnings, shrinks assets and lowers shareholders' equity. Ratios that use those figures move accordingly: return on assets, return on equity and leverage measures can all look different afterwards. An analyst comparing Stryker with a peer that has not written anything down needs to be careful, because the two profit figures are not on the same footing.
The third point is the one professionals care about most. Impairment is a signal about expectations. Management has to estimate future cash flows to support the carrying amount, and a write-down means those estimates came down. Here the charge arrived in the same release as a guidance cut. That does not prove the two share a single cause, and the facts available do not say which business the goodwill relates to. But an analyst would treat the combination as a prompt to look harder at the segments and assumptions behind the numbers.
Why analysts often adjust for it
Because a goodwill impairment is large, lumpy and non-cash, many analysts strip it out when judging underlying operating performance. That is reasonable for comparing one year with the next. Yet ignoring it entirely is a mistake. The charge is evidence about the quality of past capital allocation. A company that repeatedly buys growth and then writes it down is telling you something about how disciplined its deals are.
There is also a judgement element worth remembering. The inputs to an impairment test, such as discount rates, growth forecasts and margins, come from management. That gives scope for timing. Some firms delay write-downs; others take them in a weak quarter, when the market is already focused on bad news. For a candidate in financial statement analysis, this links to the wider theme of earnings quality: reported numbers are shaped by estimates, and good analysts ask who made them and why.
What to watch next in the Stryker case is straightforward. Look at whether the revised guidance proves cautious or realistic, whether further charges follow, and how management explains the carrying value of its remaining goodwill. Large goodwill balances relative to equity leave less cushion if more write-downs come.
Turning this into exam skill
Goodwill impairment touches several ideas at once: asset recognition, the effect on income and equity, the difference between cash and accrual accounting, and the contrast between US GAAP and IFRS. The Stryker release brings several of them together in one place, which makes it a compact case to practise on.
To check whether you can read a charge like this under time pressure, try a free 30 question mini mock exam from EduFite. If the impairment questions feel shaky, the full EduFite course walks through the mechanics and gives you structured practice to fix them.
FAQ
Is a goodwill impairment a cash expense?
No. It is a non-cash charge. The cash was spent when the acquisition was made. The impairment reduces reported earnings, assets and equity, but it does not reduce the company's cash balance in the period.
Why would a company book a goodwill impairment?
Management concludes that the acquired business is worth less than the amount carried on the balance sheet. This can follow weaker results, lower forecasts or an overpayment for the deal in the first place.
Can goodwill impairment be reversed if the business recovers?
No. Under both US GAAP and IFRS, a goodwill write-down cannot be reversed in later periods, even if conditions improve.
Should analysts ignore goodwill impairment when assessing earnings?
They often exclude it to judge underlying operations, but they should not ignore it. It signals lower expected cash flows and says something about how well past acquisitions were priced and managed.